Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Nguyen A et al. - The authors find that the NF-kB inhibitor BAY 11-7085 synergizes with MS-275. They conclude that agents inhibiting NF-kB synergize with HDAC inhibitors against synovial sarcoma.

Related Articles

Prospective Evaluation of TLE1 as a Diagnostic Immunohistochemical Marker in Synovial Sarcoma
American Journal of Surgical Pathology, 11/25/09    Relevance Score: 67%

Synovial sarcoma of the thoracic spine
The Spine Journal, 11/23/09    Relevance Score: 67%

Synovial Sarcoma Presenting as Iliotibial Band Friction Syndrome
The Journal of Knee Surgery, 11/19/09    Relevance Score: 67%

Postirradiation Sarcoma: Clinicopathologic Features and Role of Chemotherapy in the Treatment Strategy
Sarcoma, 11/23/09    Relevance Score: 46%

Coincident expression of beta-catenin and cyclin D1 in endometrial stromal tumors and related high-grade sarcomas
Modern Pathology, 11/11/09    Relevance Score: 46%

Today in Basic Science/Genetics...keeping you current

Targeted proteasome inhibition by Velcade induces apoptosis in human mesothelioma and breast cancer cell lines
Cancer Chemotherapy and Pharmacology, 12/15/09

Differential Thymidylate Synthase Expression in Different Variants of Large-Cell Carcinoma of the Lung
Clinical Cancer Research, 12/15/09

miR-195 and miR-483-5p Identified as Predictors of Poor Prognosis in Adrenocortical Cancer
Clinical Cancer Research, 12/15/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address